Central Nervous System Injury - A Newly Observed Bystander Effect of Radiation.
The unintended side effects of cancer treatment are increasing recognized. Among these is a syndrome of long-term neurocognitive dysfunction called cancer/chemotherapy related cognitive impairment. To date, all studies examining the cognitive impact of cancer treatment have emphasized chemotherapy. Radiation-induced bystander effects have been described in cell culture and, to a limited extent, in rodent model systems. The purpose of this study was to examine, for the first time, the impact of non-brain directed radiation therapy on the brain in order to elucidate its potential relationship with cancer/chemotherapy related cognitive impairment. To address this objective, female BALB/c mice received either a single 16 gray fraction of ionizing radiation to the right hind limb or three doses of methotrexate, once per week for three consecutive weeks. Mice were sacrificed either 3 or 30 days post-treatment and brain injury was determined via quantification of activated astrocytes and microglia. To characterize the effects of non-brain directed radiation on brain glucose metabolism, mice were evaluated by fluorodeoxygluocose positron emission tomography. A single fraction of 16 gray radiation resulted in global decreases in brain glucose metabolism, a significant increase in the number of activated astrocytes and microglia, and increased TNF-α expression, all of which lasted up to 30 days post-treatment. This inflammatory response following radiation therapy was statistically indistinguishable from the neuroinflammation observed following methotrexate administration. In conclusion, non-brain directed radiation was sufficient to cause significant brain bystander injury as reflected by multifocal hypometabolism and persistent neuroinflammation. These findings suggest that radiation induces significant brain bystander effects distant from the irradiated cells and tissues. These effects may contribute to the development of cognitive dysfunction in treated human cancer patients and warrant further study.
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, United States of America.
Caitlin
C
Feiock
Department of Therapeutic Radiology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Masashi
M
Yagi
School of Statistics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Adam
A
Maidman
School of Statistics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Aaron
A
Rendahl
Department of Therapeutic Radiology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Susanta
S
Hui
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, United States of America.
Davis
D
Seelig
Br J Cancer. 2013 Jan 15;108(1):91-8
23321513
PLoS One. 2012;7(10):e46915
23071661
Brain Res Bull. 2012 Oct 1;89(1-2):50-6
22796103
Cytokine. 2015 Mar;72(1):86-96
25573802
J Oncol Pract. 2007 Mar;3(2):54-9
20859374
Auton Neurosci. 2000 Dec 20;85(1-3):60-5
11189027
Oncotarget. 2016 Jul 5;7(27):41622-41636
27223435
Int Rev Psychiatry. 2014 Feb;26(1):102-13
24716504
J Chem Neuroanat. 2005 Oct;30(2-3):144-57
16122904
Int J Radiat Biol. 2005 Dec;81(12):887-99
16524844
Cancer Med. 2014 Jun;3(3):702-9
24756915
Ann Oncol. 2008 Apr;19(4):623-9
17974553
Cancer. 2012 Apr 1;118(7):1925-32
22161750
Annu Rev Immunol. 2009;27:119-45
19302036
Rep Pract Oncol Radiother. 2014 Aug 28;20(1):12-21
25535579
Neuropharmacology. 2014 Apr;79:234-48
24291465
Urol Oncol. 2015 May;33(5):226-34
25454485
Calcif Tissue Int. 2014 May;94(5):544-52
24562595
J Neuroinflammation. 2015 Jun 06;12:114
26048578
Neurobiol Dis. 2010 Jan;37(1):26-32
19664708
Behav Brain Res. 2010 Mar 5;207 (2):265-72
19840821
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12445-50
18711141
Neurosci Biobehav Rev. 2011 Jan;35(3):729-41
20869395
Muscle Nerve. 2011 Jan;43(1):58-64
21171096
Breast Cancer Res Treat. 2007 Jul;103(3):303-11
17009108
Cancer Res. 2015 Feb 15;75(4):676-86
25687405
Hum Brain Mapp. 2012 Dec;33(12):2971-83
22095746
Cancer. 2009 Apr 15;115(8):1776-83
19224550
Radiat Res. 2011 Apr;175(4):405-15
21319986
Biomed Environ Sci. 1991 Jun;4(1-2):197-206
1910596
Nutr Hosp. 2011 Jul-Aug;26(4):737-44
22470018
Cancer Lett. 2015 Jan 1;356(1):17-21
24041870
Behav Brain Res. 2016 Feb 15;299:19-26
26602283
Brain Imaging Behav. 2013 Dec;7(4):511-23
23835929
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
24890451
Arthritis Res Ther. 2006;8(2):R53
16519795
Acta Physiol (Oxf). 2015 Jul;214(3):329-48
25912260
Am J Physiol Regul Integr Comp Physiol. 2014 Jan 1;306(1):R75-81
24196666
Clin Cancer Res. 2012 Apr 1;18(7):1954-65
22338017
Trends Neurosci. 1996 Aug;19(8):312-8
8843599
Calcif Tissue Int. 2013 Apr;92 (4):372-84
23314741
Clin Transl Imaging. 2013 Aug;1(4):null
24409422
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):795-803
20888704
Lancet. 2014 Jun 21;383(9935):2127-35
24656685
Cancer. 2016 Jan 15;122(2):258-68
26484435
Psychopharmacology (Berl). 2014 Mar;231(5):841-52
24101158
J Neuroinflammation. 2016 Jun 07;13(1):140
27266706